July 17th, 2020
•The ability to assess target engagement by candidate inhibitors in intact cells is crucial for drug discovery. This protocol describes a 384 well format cellular thermal shift assay that reliably detects cellular target engagement of inhibitors targeting either wild-type SHP2 or its oncogenic variants.
Tags
Related Videos
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Acellular and Cellular Lung Model to Study Tumor Metastasis
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
A Spheroid Killing Assay by CAR T Cells
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved